Biotech Banker Predicts More Meetings But Fewer Attendees
Biotech Banker Predicts More Meetings But Fewer Attendees
It’s tougher and tougher for people to figure out what’s the right venue for them, for whatever they’re trying to accomplish…

Biotech Banker Predicts More Meetings But Fewer Attendees
It’s tougher and tougher for people to figure out what’s the right venue for them, for whatever they’re trying to accomplish…
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.

Leave a Reply
Want to join the discussion?Feel free to contribute!